OpenURL Connection Search

Select item for more details and to access through your institution.

A phase II study of neoadjuvant atezolizumab and nab-paclitaxel in patients with anthracycline-resistant early-stage triple-negative breast cancer.
Published in:
Breast Cancer Research & Treatment, 2023, v. 199, n. 3, p. 457, doi. 10.1007/s10549-023-06929-9
By:
- Yam, Clinton;
- Mittendorf, Elizabeth A.;
- Garber, Haven R.;
- Sun, Ryan;
- Damodaran, Senthil;
- Murthy, Rashmi K.;
- Ramirez, David;
- Karuturi, Meghan;
- Layman, Rachel M.;
- Ibrahim, Nuhad;
- Rauch, Gaiane M.;
- Adrada, Beatriz E.;
- Candelaria, Rosalind P.;
- White, Jason B.;
- Ravenberg, Elizabeth;
- Clayborn, Alyson;
- Ding, Qing Qing;
- Symmans, W. Fraser;
- Prabhakaran, Sabitha;
- Thompson, Alastair M.
Publication type:
Article
PTEN in triple-negative breast carcinoma: protein expression and genomic alteration in pretreatment and posttreatment specimens.
Published in:
Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231189422
By:
- Chen, Hui;
- Ding, Qingqing;
- Khazai, Laila;
- Zhao, Li;
- Damodaran, Senthil;
- Litton, Jennifer K.;
- Rauch, Gaiane M.;
- Yam, Clinton;
- Chang, Jeffrey T.;
- Seth, Sahil;
- Lim, Bora;
- Thompson, Alastair M.;
- Mittendorf, Elizabeth A.;
- Adrada, Beatriz;
- Virani, Kiran;
- White, Jason B.;
- Ravenberg, Elizabeth;
- Song, Xingzhi;
- Candelaria, Rosalind;
- Arun, Banu
Publication type:
Article
Targeting chemotherapy resistance in mesenchymal triple-negative breast cancer: a phase II trial of neoadjuvant angiogenic and mTOR inhibition with chemotherapy.
Published in:
Investigational New Drugs, 2023, v. 41, n. 3, p. 391, doi. 10.1007/s10637-023-01357-4
By:
- Abuhadra, Nour;
- Sun, Ryan;
- Bassett Jr, Roland L.;
- Huo, Lei;
- Chang, Jeffrey T.;
- Teshome, Mediget;
- Clayborn, Alyson R.;
- White, Jason B.;
- Ravenberg, Elizabeth E.;
- Adrada, Beatriz E.;
- Candelaria, Rosalind P.;
- Yang, Wei;
- Ding, Qingqing;
- Symmans, W. Fraser;
- Arun, Banu;
- Damodaran, Senthil;
- Koenig, Kimberly B.;
- Layman, Rachel M.;
- Lim, Bora;
- Litton, Jennifer K.
Publication type:
Article
A phase II study of Mirvetuximab Soravtansine in triple-negative breast cancer.
Published in:
Investigational New Drugs, 2021, v. 39, n. 2, p. 509, doi. 10.1007/s10637-020-00995-2
By:
- Yam, Clinton;
- Rauch, Gaiane M.;
- Rahman, Tanbin;
- Karuturi, Meghan;
- Ravenberg, Elizabeth;
- White, Jason;
- Clayborn, Alyson;
- McCarthy, Pamela;
- Abouharb, Sausan;
- Lim, Bora;
- Litton, Jennifer K.;
- Ramirez, David L.;
- Saleem, Sadia;
- Stec, James;
- Symmans, W. Fraser;
- Huo, Lei;
- Damodaran, Senthil;
- Sun, Ryan;
- Moulder, Stacy L.
Publication type:
Article
Predictive Roles of Baseline Stromal Tumor-Infiltrating Lymphocytes and Ki-67 in Pathologic Complete Response in an Early-Stage Triple-Negative Breast Cancer Prospective Trial.
Published in:
Cancers, 2023, v. 15, n. 13, p. 3275, doi. 10.3390/cancers15133275
By:
- Abuhadra, Nour;
- Sun, Ryan;
- Yam, Clinton;
- Rauch, Gaiane M.;
- Ding, Qingqing;
- Lim, Bora;
- Thompson, Alastair M.;
- Mittendorf, Elizabeth A.;
- Adrada, Beatriz E.;
- Damodaran, Senthil;
- Virani, Kiran;
- White, Jason;
- Ravenberg, Elizabeth;
- Sun, Jia;
- Choi, Jaihee;
- Candelaria, Rosalind;
- Arun, Banu;
- Ueno, Naoto T.;
- Santiago, Lumarie;
- Saleem, Sadia
Publication type:
Article
Prognostic Impact of High Baseline Stromal Tumor-Infiltrating Lymphocytes in the Absence of Pathologic Complete Response in Early-Stage Triple-Negative Breast Cancer.
Published in:
Cancers, 2022, v. 14, n. 5, p. 1323, doi. 10.3390/cancers14051323
By:
- Abuhadra, Nour;
- Sun, Ryan;
- Litton, Jennifer K.;
- Rauch, Gaiane M.;
- Yam, Clinton;
- Chang, Jeffrey T.;
- Seth, Sahil;
- Bassett Jr., Roland;
- Lim, Bora;
- Thompson, Alastair M.;
- Mittendorf, Elizabeth;
- Adrada, Beatriz E.;
- Damodaran, Senthil;
- White, Jason;
- Ravenberg, Elizabeth;
- Candelaria, Rosalind;
- Arun, Banu;
- Ueno, Naoto T.;
- Santiago, Lumarie;
- Saleem, Sadia
Publication type:
Article
Phase II study of Radium‐223 dichloride combined with hormonal therapy for hormone receptor‐positive, bone‐dominant metastatic breast cancer.
Published in:
Cancer Medicine, 2020, v. 9, n. 3, p. 1025, doi. 10.1002/cam4.2780
By:
- Ueno, Naoto T.;
- Tahara, Rie K.;
- Fujii, Takeo;
- Reuben, James M.;
- Gao, Hui;
- Saigal, Babita;
- Lucci, Anthony;
- Iwase, Toshiaki;
- Ibrahim, Nuhad K.;
- Damodaran, Senthil;
- Shen, Yu;
- Liu, Diane D.;
- Hortobagyi, Gabriel N.;
- Tripathy, Debu;
- Lim, Bora;
- Chasen, Beth A.
Publication type:
Article
Palbociclib plus endocrine therapy significantly enhances overall survival of HR+/HER2− metastatic breast cancer patients compared to endocrine therapy alone in the second‐line setting: A large institutional study.
Published in:
International Journal of Cancer, 2022, v. 150, n. 12, p. 2025, doi. 10.1002/ijc.33959
By:
- Ha, Min Jin;
- Singareeka Raghavendra, Akshara;
- Kettner, Nicole M.;
- Qiao, Wei;
- Damodaran, Senthil;
- Layman, Rachel M.;
- Hunt, Kelly K.;
- Shen, Yu;
- Tripathy, Debu;
- Keyomarsi, Khandan
Publication type:
Article
Clinical implications of breast cancer tumor genomic testing.
Published in:
Breast Journal, 2020, v. 26, n. 8, p. 1565, doi. 10.1111/tbj.13966
By:
- Damodaran, Senthil;
- Sember, Quinne C.;
- Arun, Banu K.
Publication type:
Article
Epigenetically upregulating TROP2 and SLFN11 enhances therapeutic efficacy of TROP2 antibody drug conjugate sacitizumab govitecan.
Published in:
NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00573-8
By:
- Zhao, Ming;
- DiPeri, Timothy P.;
- Raso, Maria Gabriela;
- Zheng, Xiaofeng;
- Rizvi, Yasmeen Qamar;
- Evans, Kurt W.;
- Yang, Fei;
- Akcakanat, Argun;
- Roberto Estecio, Marco;
- Tripathy, Debu;
- Dumbrava, Ecaterina E.;
- Damodaran, Senthil;
- Meric-Bernstam, Funda
Publication type:
Article
Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple‐negative breast cancer.
Published in:
Cancer (0008543X), 2023, v. 129, n. 14, p. 2201, doi. 10.1002/cncr.34773
By:
- Nelson, Blessie Elizabeth;
- Saleem, Sadia;
- Damodaran, Senthil;
- Somaiah, Neeta;
- Piha‐Paul, Sarina;
- Moore, Julia Ann;
- Yilmaz, Bulent;
- Ogbonna, Deby;
- Karp, Daniel D.;
- Dumbrava, Ecaterina;
- Tsimberidou, Apostolia M.;
- Hong, David S.;
- Rodon Ahnert, Jordi;
- Milton, Denái R.;
- Zheng, Xiaofeng;
- Booser, Daniel J.;
- Ibrahim, Nuhad K.;
- Conley, Anthony P.;
- Bhosale, Priya;
- Rojas Hernandez, Cristhiam M.
Publication type:
Article
Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancer.
Published in:
Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-46586-y
By:
- Saridogan, Turcin;
- Akcakanat, Argun;
- Zhao, Ming;
- Evans, Kurt W.;
- Yuca, Erkan;
- Scott, Stephen;
- Kirby, Bryce P.;
- Zheng, Xiaofeng;
- Ha, Min Jin;
- Chen, Huiqin;
- Ng, Patrick K. S.;
- DiPeri, Timothy P.;
- Mills, Gordon B.;
- Rodon Ahnert, Jordi;
- Damodaran, Senthil;
- Meric-Bernstam, Funda
Publication type:
Article

Found: 12